AUSTIN, Texas, Oct. 27, 2026 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company"), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the third quarter ended September 30, 2026, of $0.08 per share of common stock of the Company and per common unit of limited partnership interest in Summit Hotel OP, LP, the Company's operating partnership. The Company's third quarter common dividend represents an annualized dividend yield of 4.6 percent based on the closing price of shares of the common stock on October 26, 2026.

The Board of Directors has also authorized, and the Company has declared, a cash dividend of $0.390625 per share of the Company's 6.25% Series E Cumulative Redeemable Preferred Stock for the dividend period ending on November 30, 2026, and a cash dividend of $0.3671875 per share of the Company's 5.875% Series F Cumulative Redeemable Preferred Stock for the dividend period ending on November 30, 2026.

Additionally, the Board of Directors has authorized a cash distribution, and the Company has declared on behalf of the operating partnership, distributions of $0.328125 per unit pertaining to the operating partnership's unregistered 5.25% Series Z Cumulative Perpetual Preferred Units for the distribution period ending on November 30, 2026.

The dividends are payable on November 30, 2026, to holders of record as of November 16, 2026.

About Summit Hotel Properties

Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused on owning premium-branded lodging properties with efficient operating models primarily in the Upscale segment of the lodging industry. As of October 27, 2026, the Company's portfolio consisted of 92 assets, 50 of which are wholly owned, with a total of 14,027 guestrooms located in 24 states.

For additional information, please visit the Company's website, www.shpreit.com, and follow the Company on X, formerly Twitter, at @SummitHotel_INN.

Forward Looking Statements

This press release contains statements that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as "may," "will," "should," "potential," "intend," "expect," "seek," "anticipate," "estimate," "approximately," "believe," "could," "project," "predict," "forecast," "continue," "plan," "likely," "would" or other similar words or expressions. These forward-looking statements relate to the payment of dividends. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company's control, which could cause actual results to differ materially from such statements. These risks and uncertainties include, but are not limited to, the state of the U.S. economy, supply and demand in the hotel industry and other factors as are described in greater detail in the Company's filings with the Securities and Exchange Commission, including, without limitation, the Company's Annual Report on Form 10-K for the year ended December 31, 2025. Unless legally required, the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Summit Hotel Properties, Inc.

Share this article

Revenue increased 14% sequentially and Net Income improved by $18M;

further significant gains expected in 4Q 2026

IP Optical Networks Revenue increased 17% QoQ led by new wins in North America

Cloud and Edge Revenue increased 11% QoQ led by U.S. Tier 1 Network Modernization

Growing Pipeline of Data Center and AI-related Opportunities

PLANO, Texas, Oct. 27, 2026 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global leader in real-time communications technology, IP routing, and optical networking solutions, today announced its financial results for the third quarter of 2026.

Third Quarter 2026 Highlights

Financial Results¹:

- Revenue was $219 million, compared to $215 million for the third quarter of 2025

- GAAP Operating Income was $6 million, compared to $3 million for the third quarter of 2025

- Non-GAAP Adjusted EBITDA was $27 million, compared to $29 million for the third quarter of 2025

- GAAP Gross Margin was 48.2%, compared to 50.1% for the third quarter of 2025

- Non-GAAP Gross Margin was 50.3%, compared to 52.6% for the third quarter of 2025

"We had meaningful sequential increases in revenue and profitability in both of our operating segments again in the third quarter, consistent with our second quarter results commentary. The strong IP Optical Networks bookings trend in the first half of the year translated into a record third quarter sales for the business, growing 5% year over year and included two new U.S. Tier 2 Internet Service Provider customers," stated Bruce McClelland, President and Chief Executive Officer of Ribbon Communications. "We are also encouraged by increased activity in the Cloud and Edge segment with Service Provider revenue growing 15% sequentially supported by a 50% increase in sales to our largest customer, along with further growth in the Enterprise and Government market segments. This progress clearly supports the second-half improvement we expected, with positive trends in both operating segments and stronger results projected for the fourth quarter. Looking ahead to 2027, we see further growth drivers with the adoption of voice-enabled Enterprise AI applications, new solutions to mitigate AI-generated voice-phishing cyber-attacks, and broader demand for data center fiber infrastructure."

Rick Marmurek, Chief Financial Officer of Ribbon Communications, remarked, "Our performance improved significantly in the third quarter, with revenue increasing 14% and Adjusted EBITDA more than doubling to $27 million from $12 million in the second quarter. At the same time, Non-GAAP operating expenses remained at $88 million. We continue to focus on expanding margins, maintaining strong cost discipline, and further strengthening our balance sheet."

Business Highlights:

- HubOne Selects Ribbon's PSX to Unify Voice Traffic Across Its Applications

- Ribbon's Optical and DCI Solutions Enable PT Jala Lintas Media (JLM) to Unlock Subsea and Metro Network Capacity Between Indonesia and Singapore

- Ribbon Bolsters Its Market-Leading Critical Infrastructure Portfolio

- Ribbon and TNS Simplify Legacy Voice Switch Replacement

Business Outlook2

For the fourth quarter of 2026, the Company projects revenue of $233 million to $247 million. Non-GAAP gross margin is projected in a range of 53.5% to 54.5%. Adjusted EBITDA is projected in a range of $40 million to $47 million.

The Company's outlook is based on current indications for its business, which are subject to change.

Upcoming Conference Schedule

- November 10-12, 2026: Ribbon Insights, U.S.

- November 19, 2026: Needham Virtual Technology Conference

- December 1, 2026: UBS Global Technology & AI Conference

Conference Call and Webcast Information

Ribbon Communications will host a conference call to discuss the Company's financial results at 4:30 p.m. ET on Tuesday, October 27, 2026.

Dial-in Information:

US/Canada: 877-407-2991

International: 201-389-0925

Instant Telephone Access: Call me⢠

A live (listen-only) webcast and replay will be available on the Company's Investor Relations website at investors.ribboncommunications.com.

Investor Contact

+1 (978) 614-8050

[email protected]

Media Contact

Catherine Berthier

+1 (646) 741-1974

[email protected]

About Ribbon

Ribbon Communications (Nasdaq: RBBN) is a global provider of voice communications software, IP routing, and optical networking to mobile and wireline service providers, enterprises, critical infrastructure and defense sectors. We support our customers' Path to Autonomous Networks by leveraging the latest AIOps automation platforms and Agentic AI technologies, helping them deliver better customer experiences, reduce operational costs, and achieve sustainable growth. To learn more about Ribbon, visit rbbn.com.

Important Information Regarding Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, which are subject to a number of risks and uncertainties. All statements other than statements of historical facts contained in this release, including without limitation, statements regarding Company's projected financial results for the fourth quarter 2026 and beyond; expected customer bookings, spend and timing; beliefs about the Company's business strategy, including new product introductions such as the Acumen AIOps platform; beliefs about the accelerating adoption of AI and the shift towards autonomous networking; and the timing of customer network transformation projects, are forward-looking statements. Without limiting the foregoing, the words "anticipates", "believes", "could", "estimates", "expects", "expectations", "intends", "may", "plans", "projects" and other similar language, whether in the negative or affirmative, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

Forward-looking statements are based on the Company's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are unknown and/or difficult to predict and that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, but are not limited to, unpredictable fluctuations in quarterly revenue and operating results; the impact of restructuring and cost-containment activities; impacts from new tariffs, the potential modification of, or loss of benefits under, the USMCA and other trade restrictions or taxes on our products; supply chain disruptions resulting from component availability; impacts from the wars in the Middle East and Ukraine and related economic volatility and uncertainty resulting therefrom; the impact of military call-ups of our employees in Israel; material litigation; the impact of fluctuations in interest rates; material cybersecurity and data intrusion incidents, including any security breaches resulting in the theft, transfer, or unauthorized disclosure of customer, employee, or company information; our ability to comply with applicable domestic and foreign information security and privacy laws, regulations and technology platform rules or other obligations related to data privacy and security; failure to compete successfully against telecommunications equipment and networking companies; failure to grow our customer base or generate recurring business from our existing customers; credit risks; the timing of customer purchasing decisions and our recognition of revenues; macroeconomic conditions, including inflation; our ability to adapt to rapid technological and market changes; our ability to generate positive returns on our research and development; our ability to protect our intellectual property rights and obtain necessary licenses; our ability to maintain partner, reseller, distribution and vendor support and supply relationships; the potential for defects in our products; risks related to the terms of our Credit Agreement, including our ability to comply with the maximum net leverage ratio, our ability to obtain future waivers or amendments to the Credit Agreement, and increases in the applicable interest margin; higher risks in international operations and markets; currency fluctuations; unanticipated adverse changes in legal, regulatory or tax laws; future accounting pronouncements or changes in our accounting policies; and/or failure or circumvention of our controls and procedures. We therefore caution you against relying on any of these forward-looking statements.

These factors are not intended to be an all-encompassing list of risks and uncertainties that may affect the Company's business and results from operations. Additional information regarding these and other factors can be found in the Company's reports filed with the Securities and Exchange Commission, including, without limitation, its Form 10-K for the year ended December 31, 2025. Any forward-looking statement made by the Company in this release speaks only as of the date on which this release was first issued. The Company undertakes no obligation to update any forward-looking statement publicly or otherwise, whether as a result of new information, future developments or otherwise, except as required by law.

Discussion of Non-GAAP Financial Measures

The Company's management uses several different financial measures, both GAAP and non-GAAP, in analyzing and assessing the overall performance of its business, making operating decisions, planning and forecasting future periods, and determining payments under compensation programs. The Company considers the use of non-GAAP financial measures helpful in assessing the core performance of its continuing operations and when planning and forecasting future periods.

STAMFORD, Conn., Oct. 27, 2026 /PRNewswire/ -- Charter Communications, Inc. (NASDAQ: CHTR, CHTRP) (the "Company") today announced that its Board of Directors declared the regular quarterly cash dividend payable to holders of its Series A Cumulative Redeemable Preferred Stock (the "Charter Preferred Stock") (NASDAQ: CHTRP). The per share amount of the quarterly cash dividend will be $0.43750001, payable in cash on January 15, 2027 to holders of record of the Charter Preferred Stock at the close of business on December 31, 2026.

About Charter

Charter Communications, Inc. (NASDAQ: CHTR, CHTRP) is the leading broadband and video company in the nation and the fastest growing mobile provider in its footprint, with services available to more than 70 million homes and small to large businesses across 45 states through its Spectrum brand. Founded in 1993, Charter has evolved from providing cable TV to streaming, and from high-speed Internet to a converged broadband, WiFi and mobile experience. Over the Spectrum Fiber Broadband Network and supported by our 100% U.S.-based employees, the Company offers Seamless Connectivity and Entertainment with Spectrum Internet®, Mobile, TV and Voice products.

More information can be found at corporate.charter.com.

SOURCE Charter Communications, Inc.

Share this article

WILMINGTON, Del., Oct. 27, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2026. The dividend will be paid on December 15, 2026, to stockholders of record as of the close of business on November 16, 2026.

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses â Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials â we deliver application expertise and chemistry-based innovations that solve customers' biggest challenges. Our flagship products are sold under prominent brands such as Opteonâ¢, Freonâ¢, Ti-Pureâ¢, Nafionâ¢, Teflonâ¢, Vitonâ¢, and Krytoxâ¢. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 5,700 employees and 28 manufacturing sites and serves approximately 2,400 customers in approximately 110 countries. For more information, visit chemours.com or follow us on LinkedIn. 

CONTACTS:

INVESTORS

Brandon Ontjes

VP, Head of Strategy & Investor Relations

+1.302.773.3300 

[email protected] 

NEWS MEDIA

Cassie Olszewski

Media Relations & Reputation Leader

+1.302.219.7140

[email protected]  

SOURCE The Chemours Company

Share this article

The article outlines how each type of pregnancy ultrasound supports fetal development and family understanding.

DENISON, Texas, Oct. 27, 2026 /PRNewswire/ -- What is the difference between 2D, 3D, and 4D ultrasound imaging during pregnancy? HelloNation has published an article that clearly explains the differences between ultrasound and other prenatal imaging modalities and how each supports fetal development.

The HelloNation article explains that a 2d ultrasound is the most common form of prenatal imaging used during routine pregnancy ultrasound appointments. It produces flat, black-and-white images that allow medical providers to assess fetal development, monitor growth, and evaluate vital structures. The article notes that 2D ultrasound plays a central role in identifying potential concerns early and remains the foundation of prenatal diagnostic imaging.

According to the article, a 3d ultrasound builds on the same technology but creates a more detailed still image with depth. This form of prenatal imaging allows families to see clearer views of the baby's face, hands, and feet. While 3d ultrasound can support certain medical evaluations, the article describes its primary value as helping parents better visualize fetal development in a more lifelike way.

The article further describes how a 4D ultrasound adds motion to the 3d ultrasound image. This allows families to view real-time video of the baby moving, stretching, or making facial expressions. The article explains that this type of pregnancy ultrasound creates a more engaging experience and helps strengthen the emotional connection, while still using the same safe, noninvasive prenatal imaging technology.

The HelloNation article emphasizes that understanding ultrasound differences helps families set clear expectations before imaging sessions. Each type of pregnancy ultrasound serves a distinct purpose. 2D ultrasound focuses on medical accuracy and fetal development monitoring, while 3D and 4D ultrasound provide enhanced visualization and connection. The article highlights that medical professionals typically rely on 2D ultrasound for diagnostic purposes, while 3D and 4D ultrasound are often optional.

The article also notes that several factors can affect the quality of prenatal imaging results. Baby position, gestational age, and fluid levels all play a role in how clearly images appear, especially during 3D and 4D ultrasound sessions. The article explains that providers often guide families on the best timing for ultrasound visits during pregnancy to improve image clarity and achieve better results.

Prenatal Imaging Experts emphasize through the article that learning about ultrasound differences can reduce uncertainty and help families feel more prepared. By understanding how each type of prenatal imaging contributes to monitoring fetal development, expectant parents can approach each pregnancy ultrasound appointment with clearer expectations.

The article concludes that while 2D ultrasound remains essential for medical care, the added perspectives of 3D and 4D ultrasound offer families a broader, more personal understanding of fetal development. Together, these forms of prenatal imaging provide both clinical insight and meaningful connection throughout pregnancy.

What Is the Difference Between 2D, 3D, and 4D Ultrasounds Explained Simply features insights from Erika Lambright, Prenatal Imaging Experts of Denison, Texas, in HelloNation.

About HelloNation

HelloNation is America's Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused digital publications and innovative "edvertising" approach, HelloNation delivers expert-driven, good-news content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities. HelloNation maintains partnerships with the U.S. Conference of Mayors and the United States First Responders Association.

SOURCE HelloNation

Share this article

Grünenthal presents Phase III results for Qutenza® in post-surgical neuropathic pain at IASP 2026 World Congress on Pain

- Late-breaking data from the Phase III RISE trial further strengthen the well-established efficacy and safety profile of Qutenza®.

- Post-surgical neuropathic pain is a debilitating complication of surgery affecting millions of patients every year.1

AACHEN, Germany, Oct. 27, 2026 /PRNewswire/ -- Grünenthal, a global leader in pain management and research, today announced new data from the Phase III RISE trial (NCT04967664), evaluating Qutenza® versus control in people with post-surgical neuropathic pain. These data were shared today as late-breaking poster presentations at the 2026 International Association for the Study of Pain (IASP) World Congress on Pain in Bangkok, Thailand.

The trial (n=409) showed that Qutenza® achieved a statistically significantly greater reduction in average pain intensity (API) than the control treatment over weeks 2-12, meeting one of its pre-specified primary endpoints. When evaluating API at week 12 specifically, at the point when patients would typically return for retreatment, the numerical difference favoured Qutenza® but did not reach statistical significance. In the extension phase of the trial, in which up to 4 retreatments were allowed, Qutenza® achieved a statistically significantly greater reduction in API than the control treatment over weeks 2-42. Safety findings were consistent with previous Qutenza® trials and no new safety signals were observed. These data support the well-established efficacy and safety profile of Qutenza®.2,3

"Post-surgical neuropathic pain can be difficult to manage with current treatment options, and there is an urgent need for patient-centred, effective solutions. The RISE trial provides encouraging evidence that Qutenza® can deliver clinically meaningful and sustained pain reduction for up to 42 weeks, having shown a greater reduction in average pain intensity than the control," said Prof. Patrice Forget, MD, PhD, FFPMRCA, Clinical Chair (full professor) in Anaesthesia, University of Aberdeen, and Honorary Consultant, NHS Grampian, Aberdeen, UK. "As IASP shines a global spotlight on neuropathic pain at this year's congress, findings such as these are important to help improve outcomes for patients and reduce the burden of pain on families and healthcare systems."

"Post-surgical neuropathic pain has been relatively understudied and continues to go under-recognised in clinical practice," said Uli Brödl, Chief Scientific Officer, Grünenthal. "These results build on the robust body of evidence for Qutenza® and reinforce its potential to provide meaningful, long-lasting pain relief for people living with pain."

Post-surgical neuropathic pain is a poorly recognised potential complication of surgery that can result in devastating outcomes. It affects millions of patients every year, with pain lasting for months or years post-procedure.1 It can also have a significant mental health impact, with patients reporting feeling extremely depressed or anxious, and having problems with daily activities.4

Qutenza® is already approved in Europe for the treatment of peripheral neuropathic pain in adults, either alone or in combination with other medicinal products for the treatment of pain.5 It is also approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia and for the treatment of neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet in adults.6

About the RISE trial2,3

The RISE (AV-001) trial is a Phase III multi-centre, randomised, double-blind, parallel-group trial to confirm the efficacy and safety of Qutenza 179mg cutaneous patch versus a low-dose capsaicin control patch in people with moderate to severe post-surgical neuropathic pain.

It included eligible adults with a 24-hour average pain intensity (API) score of 4 or more, a pain duration of 6 to 60 months after index surgery and a DN4 (Douleur Neuropathique 4) Interview score of 3 or more.

Participants were randomly assigned to receive treatment with either a 60-minute Qutenza patch (8%) or a low-dose capsaicin control patch (0.04%).

The trial had two primary endpoints:

- Change in 24-hour API from baseline to the average score of the entire period between Week 2 and Week 12.

- Change in 24-hour API from baseline to the average score at Week 12.

The primary sponsor of the trial is Averitas Pharma, Inc., Grünenthal's U.S. subsidiary.

About post-surgical neuropathic pain

Post-surgical neuropathic pain (PSNP) is defined as chronic pain with neuropathic characteristics that develops or increases after surgery and persists beyond the normal healing process. It is thought to arise, at least in part, from nerve injury and pain sensitisation associated with surgery.7

The signs and symptoms of peri- and post-surgical pain can vary based on the person and the severity of the injury caused in surgery. Reported symptoms include pain caused by stimuli that are normally painless (allodynia), abnormally increased sensitivity to pain (hyperalgesia), tingling, numbness, phantom pain and scar pain.8,9,10

About Qutenza®

In Europe, Qutenza® (capsaicin) is indicated for the treatment of peripheral neuropathic pain in adults, either alone or in combination with other medicinal products for the treatment of pain.5

Qutenza® (capsaicin) 8% topical system is approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia and for the treatment of neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet in adults. Important US safety information is available at www.qutenza.com.6

Qutenza® is a topical TRPV1 agonist, designed to provide neuropathic pain relief for up to three months through defunctionalisation of nociceptors and nerve fibre regeneration.

About Grünenthal

Grünenthal is a global leader in pain management and related diseases. As a science-based, fully integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better â and innovation is our passion. We focus all our activities and efforts on working towards our vision of a World Free of Pain.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America, and the U.S. Our products are available in approx. 100 countries. In 2025, Grünenthal employed around 4,100 people and achieved revenues of â¬1.8 billion.

More information: www.grunenthal.com

Follow us on LinkedIn & Instagram

For further information, please contact:

Matt Crabb, Head of Global Communications (Interim) at Grünenthal

References

1 Gregory P & Settles K. Pract Pain Manag. 2013;13(9):1â6.

2 Wallace M et al. Efficacy of high-concentration capsaicin patch in post-surgical neuropathic pain (RISE). Presented at the International Association for the Study of Pain World Congress 2026.

3 Wallace M et al. Safety and tolerability of high-concentration capsaicin patch in post-surgical neuropathic pain (RISE). Presented at the International Association for the Study of Pain World Congress 2026.

4 Santos MP, Lemos F, Gomes J, Romao JM, Veiga D. Br J Pain 2024;18(1):42â56.

5 European Medicines Agency. Qutenza 179 mg cutaneous patch SmPC. Available at: https://www.medicines.org.uk/emc/product/573/smpc

6 US Food and Drug Administration. Qutenza® Prescribing Information. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022395s019lbl.pdf

7 Correl D. F1000Res. 2017;6:1054.

8 Werner MU & Kongsgaard UE. Br J Anaesth. 2014;113(1):1â4.

9 Macrae WA. Br J Anaesth. 2008;101:77â86.

10 Searle RD & Simpson KH. Contin Educ Anaesth Crit Care Pain. 2010;10:12â14.

SOURCE Grünenthal Group

Share this article

BREA, Calif., Oct. 27, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced the publication of its 2025 Sustainability Report. The report provides an update on Envista's progress in expanding access to dental care, supporting employees and communities, improving environmental efficiency, and maintaining strong ethical and governance practices. The full report can be found on Envista's website.

"We are proud to release our sixth annual sustainability report as we continue to find ways to improve our impact and deliver to our customers," said Paul Keel, Chairman and CEO of Envista. "Progress continues as we make meaningful improvements in our areas of focus â delivering quality and access; supporting our people and community; safeguarding the environment; and building trust through ethical governance." Mr. Keel continued, "We are excited to build our momentum in this area, and we are looking forward to the work to come. Our progress is thanks to the many teams committed to making a meaningful impact at Envista."

Selected Highlights from Envista's 2025 Sustainability Report:

- Realized a 40% year-over-year reduction in our waste generation, along with a 19% year-over-year reduction in our water consumption.

- Donated $2.4 million with the Envista Smile Project to support increased access to care and oral health education, benefiting close to 20,000 patients through services, products, and charitable support.

- Achieved a 17% year-over-year decrease in our lost time injury rate.

The 2025 Sustainability Report provides both Envista's sustainability-related performance to date and the foundation upon which Envista will continue to identify opportunities for continuous improvement across Envista's key sustainability topics. Envista welcomes stakeholder feedback on its 2025 Sustainability Report, which can be shared via email at [email protected].

ABOUT ENVISTA

Envista is a global leader in the dental industry, uniting more than 30 trusted brandsâincluding DEXIS, Kerr, Nobel Biocare, and Ormcoâunder one mission: partnering with dental professionals to improve patients' lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare introduced the first dental implant, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and intraoral imaging, and Kerr has supported clinicians for over 135 years. Our high-performing culture is underpinned by our CIRCLe Values and the Envista Business System. Guided by these, we deliver a comprehensive portfolio of technologies, consumables, and services that empower clinicians to provide confident, efficient careâtoday and for the future. Learn more at http://envistaco.com.

CONTACT

Lauren Meinhardt

Senior Director, Corporate Communications

Envista Holdings Corporation

200 S. Kraemer Blvd., Building E

Brea, CA 92821

Telephone: (562) 383-8194

SOURCE Envista Holdings Corporation

Share this article

DALLAS, Oct. 27, 2026 /PRNewswire/ -- NexPoint Diversified Real Estate Trust ("NXDT") (NYSE: NXDT) announced today that its board of trustees has declared a quarterly cash distribution of $0.03 per common share of NXDT. The distribution will be payable on December 31, 2026, to shareholders of record on December 15, 2026. About NexPoint Diversified Real Estate Trust (NYSE: NXDT)

NexPoint Diversified Real Estate Trust is an externally advised, publicly traded, diversified REIT focused on the acquisition, development, and management of opportunistic and value-add investments throughout the United States across multiple sectors where NexPoint and its affiliates have operational expertise. NXDT is externally advised by NexPoint Real Estate Advisors X, L.P. For more information, please visit nxdt.nexpoint.com.

CONTACTS

Investor Relations

Kristen Griffith

[email protected] 

Media Relations

[email protected]

SOURCE NexPoint Diversified Real Estate Trust

Share this article

SALINAS, Calif., Oct. 27, 2026 /PRNewswire/ -- Pacific Valley Bancorp (OTC Markets: PVBK), parent company of Pacific Valley Bank, today announced its unaudited financial results for the third quarter of 2026. Net income was $1.4 million or $0.24 per share for the third quarter, exceeding the quarter ended September 30, 2025, by 45.2% as higher interest income offset higher interest and non-interest expense. Total assets increased 11.9% over the quarter ended September 30, 2025, to $667 million, total loans increased 13.5% to $589 million, and total deposits increased 11.6% to $575 million.

FINANCIAL HIGHLIGHTS:

- Net income for the quarter ended September 30, 2026, was $1.4 million, a decrease of 1.6% or $23 thousand from the quarter ended June 30, 2026. The decrease was primarily the result of higher deposit interest expense, the recognition of a credit loss provision, and higher operating expenses, partially offset by higher loan interest income. Basic earnings per share for the quarter ended September 30, 2026 was $0.24, compared to $0.19 per share for the quarter ended September 30, 2025.

- Net income for the nine months ended September 30, 2026 was $3.9 million, an increase of 39.8% or $1.1 million from the nine months ended September 30, 2025. The increase was the result of higher loan and overnight funds interest income, partially offset by higher personnel and premises expense.

- Net interest margin for the quarter ended September 30, 2026 was 3.84%, compared with 3.82% for the quarter ended June 30, 2026. The increase was the result of higher loan interest income, partially offset by higher money market interest expense. Net interest margin for the nine months ended September 30, 2026 was 3.80%, compared with 3.51% for the nine months ended September 30, 2025, due to higher loan and overnight funds interest income, partially offset by higher deposit interest expense.

- Gross loans grew by 13.5% or $70 million from September 30, 2025 to September 30, 2026, primarily due to increased non-owner occupied CRE and multifamily loans.

- Non-performing loans to gross loans for the quarter ended September 30, 2026, was 0.04%, compared to 0.05% for the quarter ended September 30, 2025.

- The Community Bank Leverage Ratio for the Company's subsidiary, Pacific Valley Bank, has been consistently strong. As of September 30, 2026, the ratio was 12.14%, compared to 12.60% on June 30, 2026, and 13.03% on September 30, 2025. The well capitalized regulatory requirement for this ratio is 8.00%.

"We are pleased to report a 45% year-over-year improvement in net income to $1.4 million in the third quarter of 2026, as we maintain growth in loans and deposits over the third quarter of 2025. Loans increased $70 million and deposits increased by $60 million from September 30, 2025. Total loans grew 13.5% year-over-year as of September 30, 2026, with 82% of that secured by collateral," said Anker Fanoe, CEO.

"Our growth strategy has matured to the point that we are achieving economies of scale and improved profitability. This trend should result in improved operational efficiency. We take great pride in the quality of the staff we have assembled and are effectively competing against the banks in our market. I am pleased to see our loans grow by $41 million in the quarter given our very high credit standards. We are making progress," stated CEO Fanoe.

"Our liquidity position remains strong, as our primary liquidity ratio (cash, deposits held in other banks, and securities as a percentage of total assets) was 10.07% on September 30, 2026, compared to 11.29% for the same month a year ago. As of September 30, 2026, on-balance sheet liquidity totaled $67 million and contingent liquidity, which includes borrowing capacity with the Federal Home Loan Bank, the Federal Reserve Bank, correspondent banks and brokered deposits, was $361 million. Our combined on-balance sheet liquidity and contingent liquidity amount to 122% of our uninsured deposits," said Steve Leen, Executive Vice President and CFO.

As of September 30, 2026, total assets were $667 million. Since September 30, 2025, total assets have increased $71.2 million or 11.9%, primarily because of an increase in loans. Since June 30, 2026, total assets have increased by $15 million or 2.3%, also due to an increase in loans, partially offset by a decrease in overnight funds.

The investment securities portfolio totaled $22 million as of September 30, 2026, $22 million as of June 30, 2026, and $25 million as of September 30, 2025; the unrealized losses in the portfolio were $0.6 million, $0.3 million, and $0.2 million for the comparable periods, respectively. The securities portfolio made up 3.4% of total assets and the unrealized loss was 2.6% of the investment portfolio as of September 30, 2026.

Total gross loans were $589 million as of September 30, 2026. Gross loans grew by 13.5% or $70 million from September 30, 2025. Increased non-owner occupied CRE and multifamily loans were the main components of the increase over the quarter ended September 30, 2025. The Company's loan portfolio increased by $41 million or 7.6% during the quarter ended September 30, 2026 compared to the quarter ended June 30, 2026. Increased multifamily and non-owner occupied CRE loans were the main factors for the increase in loans from the quarter ended June 30, 2026.

Total deposits were $575 million as of September 30, 2026. Deposits grew by 11.6% or $60 million from September 30, 2025. Increased money market accounts and certificates of deposit were the main components of the increase over the quarter ended September 30, 2025. The Company's deposits increased by $15 million or 2.7% during the quarter ended September 30, 2026 compared to the quarter ended June 30, 2026. Increased money market accounts and certificates of deposit were also the main factors for the increase in deposits from the quarter ended June 30, 2026.

Shareholders' equity was $73 million on September 30, 2026, representing growth of $13 million or 21.4% over a year ago, primarily attributable to the Taylor Fresh Foods capital raise and increased retained earnings from net income. For the Company's subsidiary, Pacific Valley Bank, equity increased to $81 million on September 30, 2026, compared to $79 million on June 30, 2026. The Bank is classified as well capitalized with a Community Bank Leverage Ratio of 12.14%, significantly above the regulatory minimum of 8.00%.

Net Interest Income was $6.2 million for the quarter ended September 30, 2026, compared to $5.0 million for the quarter ended September 30, 2025. The increase resulted from higher interest income of $1.5 million and increased interest expense of only $247 thousand. Net interest margin for the third quarter of 2026 was 3.84% compared with 3.53% for the same period in 2025. The increase was primarily the result of higher loan interest income.

Net interest income was $17.7 million for the nine months ended September 30, 2026, compared to $14.5 million for the nine months ended September 30, 2025. Net interest income was impacted by increased interest income of $3.4 million and increased interest expense of $0.2 million. Net interest margin for the nine months ended September 30, 2026 was 3.80% compared with 3.51% for the same period in 2025. The increase was primarily the result of higher loan interest income.

A provision for credit losses of $149 thousand was recorded in the nine months ended September 30, 2026 while no provision was recorded in the nine months ended September 30, 2025. The credit loss provision resulted from the growth in the loan portfolio. The allowance for credit losses was 1.38% of gross loans as of September 30, 2026. Credit quality remains very strong; non-performing loans to gross loans as of September 30, 2026 was 0.04% compared to 0.05% as of September 30, 2025.

For the quarter ended September 30, 2026, non-interest income was $376 thousand compared to $383 thousand for the quarter ended September 30, 2025, and $378 thousand for the quarter ended June 30, 2026.

Year to date non-interest expense was $13.1 million compared with $11.8 million for the nine months ended September 30, 2025, an increase of $1.3 million, or 10.7%. The increase was primarily caused by higher personnel expenses of $0.5 million and premises expense of $0.3 million. Non-interest expense was $4.5 million for the third quarter of 2026, an increase of $0.5 million, or 11.3%, compared to the quarter ended September 30, 2025, primarily related to higher personnel and premises expense.

Return on average assets was 0.82% for the nine months ended September 30, 2026, versus 0.66% for the comparable period of the prior year due to higher loan interest and overnight funds income, partially offset by higher deposit interest, personnel and premises expense. Return on average assets was 0.83% for the three months ended September 30, 2026, versus 0.89% for the three months ended June 30, 2026, due to the recognition of a credit loss provision, higher deposit interest expense, and higher operating expense, partially offset by higher loan interest income.

ABOUT PACIFIC VALLEY BANCORP:

Pacific Valley Bancorp completed its formation and reorganization as a bank holding company for Pacific Valley Bank on January 4, 2022. The Company is a registered bank holding company with the Federal Reserve Bank, but it has not registered its securities under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, and it therefore does not file periodic reports with the Securities and Exchange Commission.

Pacific Valley Bank is a full service business bank that commenced operations in September 2004 to provide exceptional service to customers in Monterey County. Pacific Valley Bank operates business at four locations; administrative headquarters and branch offices in Salinas, King City, Monterey and Santa Cruz, California.

DALLAS, Oct. 27, 2026 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) announced today that its board of directors has declared a quarterly regular dividend of $0.50 per share of NREF common stock. The dividend will be payable on December 31, 2026, to stockholders of record on December 15, 2026.

About NexPoint Real Estate Finance, Inc.

NexPoint Real Estate Finance, Inc., is a publicly traded REIT, with its common stock and Series A Preferred Stock listed on the New York Stock Exchange under the symbol "NREF" and "NREF PRA," respectively, primarily focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, promissory notes and common equity investments, as well as multifamily and single-family commercial mortgage-backed securities securitizations, and mortgage-backed securities. More information about the Company is available at http://nref.nexpoint.com.

CONTACTS

Investor Relations

Kristen Thomas

[email protected] 

Media Relations

Prosek Partners for NexPoint

[email protected]

SOURCE NexPoint Real Estate Finance, Inc.

Share this article